AAAAAA
Results:
1-14
|
Results: 14
Authors:
Van Liefde, I
Vanderheyden, PML
De Backer, JP
Ebinger, G
Vauquelin, G
Citation: I. Van Liefde et al., Effects of BIBP3226 and BIBP3435 on cytosolic calcium in neuropeptide YY1 receptor-transfected Chinese hamster ovary cells and wild type CHO-K1 cells, J RECEPT SI, 21(1), 2001, pp. 11-23
Authors:
Vauquelin, G
Morsing, P
Fierens, FLP
De Backer, JP
Vanderheyden, PML
Citation: G. Vauquelin et al., A two-state receptor model for the interaction between angiotensin II type1 receptors and non-peptide antagonists, BIOCH PHARM, 61(3), 2001, pp. 277-284
Authors:
Fierens, FLP
Vanderheyden, PML
Roggeman, C
De Backer, JP
Thekkumkara, TJ
Vauquelin, G
Citation: Flp. Fierens et al., Tight binding of the angiotensin AT(1) receptor antagonist [H-3]candesartan is independent of receptor internalization, BIOCH PHARM, 61(10), 2001, pp. 1227-1235
Authors:
Verheijen, I
Fierens, FLP
DeBacker, JP
Vauquelin, G
Vanderheyden, PML
Citation: I. Verheijen et al., Interaction between the partially insurmountable antagonist valsartan and human recombinant angiotensin II type 1 receptors, FUN CL PHAR, 14(6), 2000, pp. 577-585
Authors:
Vanderheyden, PML
Verheijen, I
Fierens, FLP
DeBacker, JP
Vauquelin, G
Citation: Pml. Vanderheyden et al., Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT(1) receptors, PHARM RES, 17(12), 2000, pp. 1482-1488
Authors:
Vanderheyden, PML
Fierens, FLP
Vauquelin, G
Citation: Pml. Vanderheyden et al., Angiotensin II type 1 receptor antagonists - Why do some of them produce insurmountable inhibition?, BIOCH PHARM, 60(11), 2000, pp. 1557-1563
Authors:
Vanderheyden, PML
Fierens, FLP
De Backer, JP
Vauquelin, G
Citation: Pml. Vanderheyden et al., Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type I receptors, BIOCH PHARM, 59(8), 2000, pp. 927-935
Authors:
Vauquelin, G
Fierens, FLP
de Backer, JP
Vanderheyden, PML
Citation: G. Vauquelin et al., The effects of candesartan on human AT(1) receptor-expressing Chinese hamster ovary cells, J AM S NEPH, 10, 1999, pp. S15-S17
Authors:
Fierens, F
Vanderheyden, PML
De Backer, JP
Vauquelin, G
Citation: F. Fierens et al., Binding of the antagonist [H-3]candesartan to angiotensin II AT(1) receptor-transfected Chinese hamster ovary cells (vol 367, pg 413, 1999), EUR J PHARM, 373(1), 1999, pp. 125-125
Authors:
Fierens, FLP
Vanderheyden, PML
De Backer, JP
Vauquelin, G
Citation: Flp. Fierens et al., Insurmountable angiotensin AT(1) receptor antagonists: the role of tight antagonist binding, EUR J PHARM, 372(2), 1999, pp. 199-206
Authors:
Fierens, F
Vanderheyden, PML
De Backer, JP
Vauquelin, G
Citation: F. Fierens et al., Binding of the antagonist [H-3]candesartan to angiotensin II AT(1) receptor-tranfected Chinese hamster ovary cells, EUR J PHARM, 367(2-3), 1999, pp. 413-422
Authors:
Vanderheyden, PML
Fierens, FLP
De Backer, JP
Fraeyman, N
Vauquelin, G
Citation: Pml. Vanderheyden et al., Distinction beta een surmountable and insurmountable selective AT(1) receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT(1) receptors, BR J PHARM, 126(4), 1999, pp. 1057-1065
Authors:
Le, MT
Vanderheyden, PML
De Backer, JP
Vanquelin, G
Vanden Broeck, J
Citation: Mt. Le et al., High affinity displacement of [H-3]NPY binding to the crude venom of Conusanemone by insect neuropeptides, BIOC BIOP R, 262(1), 1999, pp. 180-186
Authors:
Vanderheyden, PML
Van Liefde, I
de Backer, JP
Vauquelin, G
Citation: Pml. Vanderheyden et al., [H-3]-BIBP3226 and [H-3]-NPY binding to intact SK-N-MC cells and CHO cellsexpressing the human Y-1 receptor, J RECEPT SI, 18(4-6), 1998, pp. 363-385
Risultati:
1-14
|